Net profit of Brawn Biotech reported to Rs 0.07 crore in the quarter ended September 2025 as against net loss of Rs 0.34 crore during the previous quarter ended September 2024. Sales rose 48.18% to Rs 4.89 crore in the quarter ended September 2025 as against Rs 3.30 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales4.893.30 48 OPM %0.20-9.39 - PBDT0.10-0.31 LP PBT0.07-0.34 LP NP0.07-0.34 LP Powered by Capital Market - Live News

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live News

Brawn Biotech announced that the Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live News

Net profit of Brawn Biotech reported to Rs 0.24 crore in the quarter ended June 2025 as against net loss of Rs 0.53 crore during the previous quarter ended June 2024. Sales rose 42.86% to Rs 5.80 crore in the quarter ended June 2025 as against Rs 4.06 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales5.804.06 43 OPM %3.10-12.32 - PBDT0.27-0.50 LP PBT0.24-0.53 LP NP0.24-0.53 LP Powered by Capital Market - Live News

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 13 August 2025.Powered by Capital Market - Live News